Late Stage Investors & VC Firms in Switzerland

56 firms in this list, with a median first check of $3.2M. 7 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
EQ EQT Life Sciences MKPFBJDB59 people · Leads rounds	88🔒	Amsterdam	NL	Seed–Late Stage	$11M – $66M	+ Add to CRM
EU Eurazeo CBWKLGLM35 people	88🔒	Paris	FR	Seed–Late Stage	—	+ Add to CRM
GI Gilde Healthcare AFEDGPHD26 people · Follows rounds	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $55M	+ Add to CRM
BO Bootstrap Europe FDSHESHN23 people	88🔒	London	GB	Growth–Late Stage	—	+ Add to CRM
+N +ND Capital ASEMKKKD17 people · Leads rounds	88🔒	Woodside	US	Seed–Late Stage	$540K – $5.4M	+ Add to CRM
CA Capiton AG CKFWFFGT29 people	88🔒	Berlin	DE	Growth–Late Stage	—	+ Add to CRM
T. T.Capital MSOSTSAJ23 people	88🔒	Hamburg	DE	Seed–Late Stage	—	+ Add to CRM
CR Creathor Ventures GKKS2 people	88🔒	Bad Homburg	DE	Seed–Late Stage	$540K – $10.8M	+ Add to CRM
VE Vesper Infrastructure Partners AMERGRGR19 people	88🔒	London	GB	Growth–Late Stage	—	+ Add to CRM
PA PAI Partners AAKBAAWP13 people	88🔒	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
KK KKA DFKNPFJS19 people	88🔒	Berlin	DE	Growth–Late Stage	—	+ Add to CRM
IN Infinitas Capital RLRHSLAC17 people	88🔒	—		Pre-Seed–Late Stage	—	+ Add to CRM
AG AG Capital DJKLKMJO15 people	88🔒	Vienna	AT	Growth–Late Stage	—	+ Add to CRM
RO Rosetta Capital Ltd. JHKMMFDL8 people	88🔒	Oxford	GB	Growth–Late Stage	—	+ Add to CRM
CL CLI Ventures ZLJSZPXC6 people	88🔒	Palo Alto	US	Seed–Late Stage	—	+ Add to CRM
EG Egeria CKEPHRJK11 people	88🔒	Amsterdam	NL	Growth–Late Stage	—	+ Add to CRM
TA Target Partners BVDTJWMK7 people	88🔒	Munich	DE	Seed–Late Stage	$1.1M – $3.2M	+ Add to CRM
SE Sectoral Asset Management FBGDMSMM8 people	88🔒	Montreal	CA	Series B–Late Stage	—	+ Add to CRM
VE Vesalius Biocapital III Partners SàRL CSGGMLSV11 people	88🔒	Contern	LU	Series B–Late Stage	$10.8M	+ Add to CRM
NA naturalX Health Ventures MACPSBYC4 people · Leads rounds	88🔒	Karlsruhe	DE	Seed–Late Stage	$3.2M – $5.4M	+ Add to CRM
ME Merifin Capital SHCWCTJH5 people	88🔒	Brussels	BE	Seed–Late Stage	$216K – $3.2M	+ Add to CRM
BU Butler Industries EBLPPCWB4 people	88🔒	Paris	FR	Growth–Late Stage	$10.8M – $54M	+ Add to CRM
ED EDB Investments CGCKCLJO11 people	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
NG NGN Capital KAACPJWJ5 people	88🔒	New York	US	Series A–Late Stage	—	+ Add to CRM

EQT Life Sciences

AmsterdamSeed–Late Stage$11M – $66M

MKPFBJDB59 people

Eurazeo

ParisSeed–Late Stage

CBWKLGLM35 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $55M

AFEDGPHD26 people

Bootstrap Europe

LondonGrowth–Late Stage

FDSHESHN23 people

+ND Capital

WoodsideSeed–Late Stage$540K – $5.4M

ASEMKKKD17 people

Capiton AG

BerlinGrowth–Late Stage

CKFWFFGT29 people

T.Capital

HamburgSeed–Late Stage

MSOSTSAJ23 people

Creathor Ventures

Bad HomburgSeed–Late Stage$540K – $10.8M

GKKS2 people

Vesper Infrastructure Partners

LondonGrowth–Late Stage

AMERGRGR19 people

PAI Partners

ParisGrowth–Late Stage$108M – $324M

AAKBAAWP13 people

KKA

BerlinGrowth–Late Stage

DFKNPFJS19 people

Infinitas Capital

Pre-Seed–Late Stage

RLRHSLAC17 people

AG Capital

ViennaGrowth–Late Stage

DJKLKMJO15 people

Rosetta Capital Ltd.

OxfordGrowth–Late Stage

JHKMMFDL8 people

CLI Ventures

Palo AltoSeed–Late Stage

ZLJSZPXC6 people

Egeria

AmsterdamGrowth–Late Stage

CKEPHRJK11 people

Target Partners

MunichSeed–Late Stage$1.1M – $3.2M

BVDTJWMK7 people

Sectoral Asset Management

MontrealSeries B–Late Stage

FBGDMSMM8 people

Vesalius Biocapital III Partners SàRL

ConternSeries B–Late Stage$10.8M

CSGGMLSV11 people

naturalX Health Ventures

KarlsruheSeed–Late Stage$3.2M – $5.4M

MACPSBYC4 people

Merifin Capital

BrusselsSeed–Late Stage$216K – $3.2M

SHCWCTJH5 people

Butler Industries

ParisGrowth–Late Stage$10.8M – $54M

EBLPPCWB4 people

EDB Investments

SingaporeSeed–Late Stage

CGCKCLJO11 people

NGN Capital

New YorkSeries A–Late Stage

KAACPJWJ5 people

Data sourced from public filings and firms' own websites — see our methodology.